Insider trading · Q3 2026 · CIK 1933567

Neuraxis, INC (NRXS) insider trading.

In Q3 2026, insiders at Neuraxis, INC reported 9 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
9
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
7
Last filed
2026-08-26

Insiders

InsiderRelationshipTransactionsBuysSales
Aharon GilDirector300
Carrico Brian AllenDirector, Officer · Chief Executive Officer100
Carrico Thomas JoesephOfficer · CRO, CCO, CPO100
Miranda AdrianOfficer · CMO, SVP Science & Tech100
Ferge Kristin ADirector100
Keyser Jane ElizabethDirector100
Watkins Bradley MitchellDirector100

Transactions

9 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-24Carrico Brian AllenA (A)199,188—227,336Form 4
2026-08-24Carrico Thomas JoesephA (A)193,678—199,345Form 4
2026-08-24Miranda AdrianA (A)199,106—199,106Form 4
2026-08-13Aharon GilA (A)43,930$6.2880,058Form 4
2026-08-13Ferge Kristin AA (A)31,134$6.2867,072Form 4
2026-08-13Keyser Jane ElizabethA (A)26,073$6.2872,408Form 4
2026-08-13Watkins Bradley MitchellA (A)26,073$6.2872,408Form 4
2026-07-29Aharon GilA (A)2,226—36,128Form 4
2026-07-29Aharon GilA (A)40,068—548,123Form 4

Transaction codes in this quarter

Get NRXS insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1933567&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · NRXS company page · Neuraxis, INC on SEC.gov

Questions

Are insiders buying or selling Neuraxis, INC (NRXS)?

In Q3 2026, insiders at Neuraxis, INC reported 9 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Neuraxis, INC insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/nrxs.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.